Provided by Tiger Fintech (Singapore) Pte. Ltd.

NRX Pharmaceuticals Inc.

2.05
-0.0260-1.25%
Pre-market: 2.170.1200+5.85%09:14 EDT
Volume:96.59K
Turnover:199.80K
Market Cap:34.74M
PE:-0.87
High:2.10
Open:2.09
Low:2.03
Close:2.08
Loading ...
Oct 13, 2021

Major Issues Report

8-K - Current report
Sep 13, 2021

Correspondence

CORRESP [Cover] - Correspondence
Sep 10, 2021

Major Issues Report

8-K - Current report
Sep 03, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Aug 24, 2021

Major Issues Report

8-K - Current report
Aug 20, 2021

Major Issues Report

8-K - Current report
Aug 19, 2021

Major Issues Report

8-K - Current report
Aug 16, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 29, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jul 07, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jul 06, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jun 25, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Jun 04, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 03, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
May 28, 2021

Major Issues Report

8-K - Current report
May 28, 2021

Major Issues Report

8-K - Current report
May 26, 2021

Major Issues Report

8-K - Current report
May 26, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 24, 2021

Major Issues Report

8-K - Current report
May 24, 2021

Delisting

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities